Database distributorship - geneXplain geneXplain
TRANSFAC® and TRANSPATH® are registered trademarks of QIAGEN, the contents of the mentioned databases are subject to copyright (© Copyright (2016) QIAGEN GmbH).

TRANSFAC® is the gold standard in transcription regulation, providing information about the involved components (transcription factors, TF, and their genomic binding sites) as well as the largest library of TF binding site models (i.e., positional weight matrices) to be used for the prediction of potential binding sites in DNA sequences.


TRANSPATH® is one of the largest signaling network databases. It has been integrated with the PROTEOME database, but is also available as stand-alone product. Both TRANSFAC and TRANSPATH are valuable resources to fully exploit the capablities of geneXplain’s proprietary upstream analysis implemented in the geneXplain platform.

PROTEOMETM has been a collection of databases about the completre proteomes of different organisms. Its volume HumanPSD (Human Proteome Survey Database) is a comprehensive encyclopedia of the disease associations of human, mouse and rat proteins. Its particular value lies in the identification of known and potential biomarkers.

Database distributorship

As of July 7, 2016, geneXplain has been granted a world-wide, exclusive and perpetual license to further develop, maintain and commercialize the former BIOBASE databases TRANSFAC®, TRANSPATH® and PROTEOMETM.

News

Find history in our archive.
September 23, 2021

Join us for geneXplain’s open day devoted to the World Cancer Research Day on September 23rd at 3 PM CEST. Check the event page for further info and registration details.

September 10, 2021

Basel Computational Biology Conference Logo

Don’t miss the chance to attend geneXplain’s contribution to the BioNetVisA workshop at the [BC]2 conference on Monday September 13, 2021.
In his online-talk entitled “Personalized anti-cancer drug treatment choice using RNA-seq and network analysis” Dr. Alexander Kel will present the application of Genome Enhancer to cancer patient data.

×